These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23450449)

  • 1. Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.
    Koumarianou A; Chatzellis E; Boutzios G; Tsavaris N; Kaltsas G
    Endokrynol Pol; 2013; 64(1):60-72. PubMed ID: 23450449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.
    Strosberg JR; Coppola D; Klimstra DS; Phan AT; Kulke MH; Wiseman GA; Kvols LK;
    Pancreas; 2010 Aug; 39(6):799-800. PubMed ID: 20664477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].
    Pellat A; Wislez M; Svrcek M; Hammel P; Afchain P; André T
    Bull Cancer; 2016 Oct; 103(10):880-895. PubMed ID: 27507031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired Box 5 (PAX5) Expression in Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal and Pancreatobiliary Tract: Diagnostic and Potentially Therapeutic Implications.
    Ainechi S; Mann SA; Lin J; Patil D; Sheehan CE; Yang Z; Zuo C; Lee H
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):545-551. PubMed ID: 27941564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
    Fazio N; Milione M
    Cancer Treat Rev; 2016 Nov; 50():61-67. PubMed ID: 27636009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic disease in patients with neuroendocrine tumors.
    Niederhuber JE; Fojo T
    Surg Oncol Clin N Am; 2006 Jul; 15(3):511-33, viii. PubMed ID: 16882495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas.
    Smith J; Reidy-Lagunes D
    Semin Oncol; 2013 Feb; 40(1):100-8. PubMed ID: 23391117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.
    Crippa S; Partelli S; Belfiori G; Palucci M; Muffatti F; Adamenko O; Cardinali L; Doglioni C; Zamboni G; Falconi M
    World J Gastroenterol; 2016 Dec; 22(45):9944-9953. PubMed ID: 28018101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.
    Rinke A; Gress TM
    Digestion; 2017; 95(2):109-114. PubMed ID: 28161703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
    Walter T; Tougeron D; Baudin E; Le Malicot K; Lecomte T; Malka D; Hentic O; Manfredi S; Bonnet I; Guimbaud R; Coriat R; Lepère C; Desauw C; Thirot-Bidault A; Dahan L; Roquin G; Aparicio T; Legoux JL; Lombard-Bohas C; Scoazec JY; Lepage C; Cadiot G;
    Eur J Cancer; 2017 Jul; 79():158-165. PubMed ID: 28501762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of poorly differentiated neuroendocrine carcinomas of rectum and anus with chemoradiotherapy: a single-centre evaluation.
    Fløe LE; Aggerholm-Pedersen N; Tabaksblat EM
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):114. PubMed ID: 38448660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Poorly-differentiated neuroendocrine carcinoma of ascending colon with liver metastases successfully treated with carboplatin and etoposide].
    Akiyama S; Niitani T; Narasaka T; Ohto T; Gamoh M
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1209-12. PubMed ID: 21772114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Poorly differentiated endocrine carcinoma of the colon].
    Saint-Blancard P; Hervouet M; Chapuis O
    Rev Med Interne; 2010 Jun; 31(6):e10-2. PubMed ID: 20167397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of a three-drug combination including cisplatin (CLOVER regimen) for poorly differentiated neuroendocrine carcinoma.
    Bajetta E; Catena L; Biondani P; Pusceddu S; Valente M; Bianco N; Novelli E
    Anticancer Res; 2014 Oct; 34(10):5657-60. PubMed ID: 25275070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment, prognostic markers and survival in thymic neuroendocrine tumours. a study from a single tertiary referral centre.
    Crona J; Björklund P; Welin S; Kozlovacki G; Oberg K; Granberg D
    Lung Cancer; 2013 Mar; 79(3):289-93. PubMed ID: 23286964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.
    Inno A; Bogina G; Turazza M; Bortesi L; Duranti S; Massocco A; Zamboni G; Carbognin G; Alongi F; Salgarello M; Gori S
    Oncologist; 2016 Jan; 21(1):28-32. PubMed ID: 26659223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours.
    Plöckinger U; Wiedenmann B
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):553-76. PubMed ID: 16183527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.